COVID19 ARDS
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress Syndrome (NCT04625738) | Central Hospital, Nancy, France | 2020-11-06 |
| Mild Hypothermia for COVID-19 ARDS (NCT04570462) | Northwell Health | 2020-05-18 |
Track COVID19 ARDS automatically
Every clearance here is in the API, with alerts when new ones post.